These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


239 related items for PubMed ID: 27021020

  • 1. RAS Promotes Proliferation and Resistances to Apoptosis in Meningioma.
    Jiang C, Song T, Li J, Ao F, Gong X, Lu Y, Zhang C, Chen L, Liu Y, He H, Huang O.
    Mol Neurobiol; 2017 Jan; 54(1):779-787. PubMed ID: 27021020
    [Abstract] [Full Text] [Related]

  • 2. The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats.
    Reif S, Weis B, Aeed H, Gana-Weis M, Zaidel L, Avni Y, Romanelli RG, Pinzani M, Kloog Y, Bruck R.
    J Hepatol; 1999 Dec; 31(6):1053-61. PubMed ID: 10604579
    [Abstract] [Full Text] [Related]

  • 3. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
    Feng Y, Zhou MY, Sun F, Kong Z, Wang J, Sun ZQ, Hu LJ, Wang JL, Hua Q, Yu JP.
    Zhonghua Zhong Liu Za Zhi; 2019 Apr 23; 41(4):263-275. PubMed ID: 31014051
    [Abstract] [Full Text] [Related]

  • 4. Functional inhibition of Ras by S-trans,trans-farnesyl thiosalicylic acid attenuates atherosclerosis in apolipoprotein E knockout mice.
    George J, Afek A, Keren P, Herz I, Goldberg I, Haklai R, Kloog Y, Keren G.
    Circulation; 2002 May 21; 105(20):2416-22. PubMed ID: 12021230
    [Abstract] [Full Text] [Related]

  • 5. The inhibition of human mesangial cell proliferation by S-trans, trans-farnesylthiosalicylic acid.
    Khwaja A, Sharpe CC, Noor M, Kloog Y, Hendry BM.
    Kidney Int; 2005 Aug 21; 68(2):474-86. PubMed ID: 16014024
    [Abstract] [Full Text] [Related]

  • 6. Ras inhibition in hepatocarcinoma by S-trans-trans-farnesylthiosalicyclic acid: association of its tumor preventive effect with cell proliferation, cell cycle events, and angiogenesis.
    Stärkel P, Charette N, Borbath I, Schneider-Merck T, De Saeger C, Abarca J, Leclercq I, Horsmans Y.
    Mol Carcinog; 2012 Oct 21; 51(10):816-25. PubMed ID: 21882255
    [Abstract] [Full Text] [Related]

  • 7. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B, Starinsky S, Friedman E, Stein R, Kloog Y.
    Clin Cancer Res; 2006 Sep 15; 12(18):5533-42. PubMed ID: 17000690
    [Abstract] [Full Text] [Related]

  • 8. Farnesyl thiosalicylic acid inhibits the growth of melanoma cells through a combination of cytostatic and pro-apoptotic effects.
    Smalley KS, Eisen TG.
    Int J Cancer; 2002 Apr 01; 98(4):514-22. PubMed ID: 11920610
    [Abstract] [Full Text] [Related]

  • 9. RNAi-mediated downregulation of radiation-induced MMP-9 leads to apoptosis via activation of ERK and Akt in IOMM-Lee cells.
    Gogineni VR, Kargiotis O, Klopfenstein JD, Gujrati M, Dinh DH, Rao JS.
    Int J Oncol; 2009 Jan 01; 34(1):209-18. PubMed ID: 19082492
    [Abstract] [Full Text] [Related]

  • 10. A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice.
    Weisz B, Giehl K, Gana-Weisz M, Egozi Y, Ben-Baruch G, Marciano D, Gierschik P, Kloog Y.
    Oncogene; 1999 Apr 22; 18(16):2579-88. PubMed ID: 10353601
    [Abstract] [Full Text] [Related]

  • 11. Ras inhibition by FTS attenuates brain tumor growth in mice by direct antitumor activity and enhanced reactivity of cytotoxic lymphocytes.
    Aizman E, Mor A, Levy A, George J, Kloog Y.
    Oncotarget; 2012 Feb 22; 3(2):144-57. PubMed ID: 22323550
    [Abstract] [Full Text] [Related]

  • 12. Farnesylthiosalicylic acid: inhibition of proliferation and enhancement of apoptosis of hormone-dependent breast cancer cells.
    Santen RJ, Lynch AR, Neal LR, McPherson RA, Yue W.
    Anticancer Drugs; 2006 Jan 22; 17(1):33-40. PubMed ID: 16317288
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of the Ras oncoprotein reduces proliferation of hepatocytes in vitro and in vivo in rats.
    da Silva Morais A, Saliez A, Leclercq I, Horsmans Y, Stärkel P.
    Clin Sci (Lond); 2008 Jan 22; 114(1):73-83. PubMed ID: 17678500
    [Abstract] [Full Text] [Related]

  • 14. Ras inhibition results in growth arrest and death of androgen-dependent and androgen-independent prostate cancer cells.
    Erlich S, Tal-Or P, Liebling R, Blum R, Karunagaran D, Kloog Y, Pinkas-Kramarski R.
    Biochem Pharmacol; 2006 Aug 14; 72(4):427-36. PubMed ID: 16780807
    [Abstract] [Full Text] [Related]

  • 15. Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro.
    Ragel BT, Gillespie DL, Kushnir V, Polevaya N, Kelly D, Jensen RL.
    Neurosurgery; 2006 Nov 14; 59(5):1109-20; discussion 1120-1. PubMed ID: 17143245
    [Abstract] [Full Text] [Related]

  • 16. Growth inhibition of ras-dependent tumors in nude mice by a potent ras-dislodging antagonist.
    Egozi Y, Weisz B, Gana-Weisz M, Ben-Baruch G, Kloog Y.
    Int J Cancer; 1999 Mar 15; 80(6):911-8. PubMed ID: 10074926
    [Abstract] [Full Text] [Related]

  • 17. mTORC1 inhibitors suppress meningioma growth in mouse models.
    Pachow D, Andrae N, Kliese N, Angenstein F, Stork O, Wilisch-Neumann A, Kirches E, Mawrin C.
    Clin Cancer Res; 2013 Mar 01; 19(5):1180-9. PubMed ID: 23406776
    [Abstract] [Full Text] [Related]

  • 18. Receptor tyrosine kinase inhibition by regorafenib/sorafenib inhibits growth and invasion of meningioma cells.
    Tuchen M, Wilisch-Neumann A, Daniel EA, Baldauf L, Pachow D, Scholz J, Angenstein F, Stork O, Kirches E, Mawrin C.
    Eur J Cancer; 2017 Mar 01; 73():9-21. PubMed ID: 28082204
    [Abstract] [Full Text] [Related]

  • 19. The Ras inhibitor S-trans,trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance.
    Gana-Weisz M, Halaschek-Wiener J, Jansen B, Elad G, Haklai R, Kloog Y.
    Clin Cancer Res; 2002 Feb 01; 8(2):555-65. PubMed ID: 11839677
    [Abstract] [Full Text] [Related]

  • 20. Ras antagonist inhibits growth and chemosensitizes human epithelial ovarian cancer cells.
    Beiner ME, Niv H, Haklai R, Elad-Sfadia G, Kloog Y, Ben-Baruch G.
    Int J Gynecol Cancer; 2006 Feb 01; 16 Suppl 1():200-6. PubMed ID: 16515591
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.